Evidence map›Paper›PMID 37971882›Full record

ArticleJCI insight2024

DLL4/Notch3/WNT5B axis mediates bidirectional prometastatic crosstalk between melanoma and lymphatic endothelial cells.

Sanni Alve, Silvia Gramolelli, Joonas Jukonen, Susanna Juteau, Anne Pink, Atte A Manninen, Satu Hänninen, Elisa Monto, Madeleine H Lackman, Olli Carpén and 4 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. An Itch Receptor Drives Melanoma.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. International journal of molecular sciences · 2026
    Article
  6. Review
  7. Article
  8. Unleashing Wnts: Wnt Ligands Fuel Cancer Spread.Journal of cancer biology · 2025
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Sanni AlveTranslational Cancer Medicine Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Silvia GramolelliFaculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.
Joonas JukonenTranslational Cancer Medicine Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Susanna JuteauDepartment of Pathology, Helsinki University Hospital (HUS), University of Helsinki, Helsinki, Finland.
Anne PinkTranslational Cancer Medicine Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Atte A ManninenDepartment of Plastic Surgery, Park Hospital, Helsinki University Hospital (HUS), and.
Satu HänninenDepartment of Pathology, Helsinki University Hospital (HUS), University of Helsinki, Helsinki, Finland.
Elisa MontoTranslational Cancer Medicine Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Madeleine H LackmanIndividualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Olli CarpénHelsinki Biobank, and.
Pipsa SaharinenTranslational Cancer Medicine Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Sinem KaramanIndividualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Kari VaahtomeriTranslational Cancer Medicine Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Päivi M OjalaTranslational Cancer Medicine Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
University of Helsinki · FIÅbo Akademi University · FIHelsinki University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite strong indications that interactions between melanoma and lymphatic vessels actively promote melanoma progression, the molecular mechanisms are not yet completely understood. To characterize molecular factors of this crosstalk, we established human primary lymphatic endothelial cell (LEC) cocultures with human melanoma cell lines. Here, we show that coculture with melanoma cells induced transcriptomic changes in LECs and led to multiple changes in their function. WNT5B, a paracrine signaling molecule upregulated in melanoma cells upon LEC interaction, was found to contribute to the functional changes in LECs. Moreover, WNT5B transcription was regulated by Notch3 in melanoma cells following the coculture with LECs, and Notch3 and WNT5B were coexpressed in melanoma patient primary tumor and metastasis samples. Moreover, melanoma cells derived from LEC coculture escaped efficiently from the primary site to the proximal tumor-draining lymph nodes, which was impaired upon WNT5B depletion. This supported the role of WNT5B in promoting the metastatic potential of melanoma cells through its effects on LECs. Finally, DLL4, a Notch ligand expressed in LECs, was identified as an upstream inducer of the Notch3/WNT5B axis in melanoma. This study elucidated WNT5B as a key molecular factor mediating bidirectional crosstalk between melanoma cells and lymphatic endothelium and promoting melanoma metastasis.

Indexed as

Lymphatic VesselsMelanomaAdaptor Proteins, Signal TransducingCalcium-Binding ProteinsEndothelial CellsHumansLymphatic MetastasisReceptor, Notch3Signal TransductionWnt ProteinsAdaptor Proteins, Signal TransducingCalcium-Binding ProteinsDLL4 protein, humanNOTCH3 protein, humanReceptor, Notch3WNT5B protein, humanWnt ProteinsCancerCell BiologyLymphMelanomaVascular Biology

Identifiers

PMID37971882
PMCPMC10906450
OpenAlexW4388722906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.